Abstract
Background
Contact hypersensitivity (CS) reaction in the skin is T-cell mediated immune reaction which plays a major role in the pathogenesis and chronicity of various inflammatory skin disorders and, like other delayed-type hypersensitivity (DTH) reactions, affords immunity against tumor cells and microbes. CS response is a self-limiting reaction, and interleukin (IL)-10 is considered to be a natural suppressant of cutaneous inflammatory response. Recently, it has been demonstrated that major depression is related to activation of the inflammatory response and elevation of some parameters of cell-mediated immunity. It has been suggested that such activation of the immune system may play a role in etiology of depression. If this immunoactivation is involved in etiology of depression, one would expect that antidepressant agents may have negative immunoregulatory effects. To the best of our knowledge, the effect of antidepressants on contact hypersensitivity has not been studied.
Methods
The aim of the present study was to establish the effect of prolonged desipramine or fluoxetine treatment on CS reaction to picryl chloride.
Results
Antidepressants significantly suppressed CS reaction, fluoxetine by 53% whereas desipramine by 47% compared to positive control. Moreover, desipramine and fluoxetine decreased relative weight of auxillary lymph nodes. Desipramine decreased also relative weight of inguinal lymph nodes and spleens whereas desipramine and fluoxetine increased production of IL-10 in comparison to positive control.
Conclusion
The observed effect of antidepressant drugs on CS reaction is consistent with the hypothesis that T-cell mediated immunity is targeted by antidepressants.
References
Askenase PW, Szczepanik M, Itakura A, Kiener C, Campos RA: Extravascular T-cell recruitment requires initiation begun by Va14+ invariant NKT cells and B-1 cells. Trends Immunol, 2004, 25, 441–449.
Besche V, Wiechmann N, Castor T, Trojandt S, Höhn Y, Kunkel H, Grez M et al.: Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress. J Gene Med, 2010, 12, 231–243.
Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G: Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol, 2000, 114, 295–302.
Enk AH, Katz SI: Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol, 1995, 105, 80–83.
Fei M, Wu X, Xu Q: Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A. J Allergy Clin Immunol, 2005, 116, 1350–1356.
Herzog WR, Millet I, Ferreri NR, Ramabhadran R, Schreurs J, Askenase PW: An antigen - specific DTH - initiating cell clone: Functional, phenotypical and partial molecular characterization. J Immunol, 1990, 144, 3667–3676.
Honda T, Miyachi Y, Kabashima K: The role of regulatory T cells in contact hypersensitivity. Recent Pat Inflamm Allergy Drug Discov, 2010, 4, 85–89.
Itakura A, Szczepanik M, Campos RA, Paliwal V, Majewska M, Matsuda H, Takatsu K, Askenase PW: An hour after immunization peritioneal B-1 cells are activated to migrate to limphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol, 2005, 175, 7170–7178.
Kobayashi Y: Langerhans’ cell produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology, 1997, 90, 496–501.
Koo JW, Duman RS: Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs, 2009, 10, 664–671.
Kubera M, Grygier B, Arteta B, Urbańska K, Basta-Kaim A, Budziszewska B, Leœkiewicz M et al.: Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice. Pharmacol Rep, 2009, 61, 1113–1126.
Kubera M, Holan V, Mathison R, Maes M: The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology, 2000, 25, 785–797.
Kubera M, Lin A-H, Kenis G, Bosmans E, van Bockstaele D, Maes M: Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio. J Clin Psychopharmacol, 2001, 21, 199–206.
Kubera M, Maes M, Budziszewska B, Basta-Kaim A, Leśkiewicz M, Grygier B, Rogóż Z, Lasoń W: Inhibitory effects of amantadine on the production of proinflammatory cytokines by stimulated in vitro human blood. Pharmacol Rep, 2009, 61, 1105–1112.
Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J: Prolonged desipramine treatment increases the production of interlekin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affec Disord, 2001, 63, 171–178.
Maes M, Song C, Lin A-H, Bonaccorso S, Kenis G, de Jongh R, Bosmans E, Scharpe S: Negative immunoregulatory effects of antidepressants: inhibition of inter - feron-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 1999, 20, 370–379.
Núñez MJ, Balboa J, Rodrigo E, Brenlla J, González-Peteiro M, Freire-Garabal M: Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett, 2006, 396, 247–251.
Schwarzenberger K, Udey MC: Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol, 1996, 106, 553–558.
Sikorski EE, Gerberick GF, Ryan CA, Miller CM, Ridder GM: Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fundam Appl Toxicol, 1996, 34, 25–35.
Tsuji RF, Kikuchi M, Askenase PW: Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J Immunol, 1996, 156, 4444–4450.
Tsuji RF, Szczepanik M, Kawikova I, Paliwal V, Campos RA, Itakura A, Akahira-Azuma M et al.: B-cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med, 2002, 196, 1277–1290.
Van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W, Askenase PW: Characterization of two different Ly-1+ T cell populations that mediate delayed - type hypersensitivity. J Immunol, 1984, 133, 2402–2411.
Wang J, Sun Y, Li Y, Xu Q: Aqueous extract from aerial parts of Artemisia vestita, a traditional Tibetan medicine, reduces contact sensitivity in mice by down-regulating the activation, adhesion and metalloproteinase production of T lymphocytes. Int Immunopharmacol, 2005, 5, 407–415.
**a Z, DePierre JW, Nässberger L: Tricyclic antidepressants inhibit I6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-y in T cells. Immunopharmacology, 1996, 34, 27–37.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kubera, M., Curzytek, K., Majewska-Szczepanik, M. et al. Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol. Rep 64, 714–722 (2012). https://doi.org/10.1016/S1734-1140(12)70866-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1734-1140(12)70866-6